{"id":47,"date":"2008-04-19T21:12:49","date_gmt":"2008-04-19T12:12:49","guid":{"rendered":"http:\/\/haruko.km2m.net\/2008\/04\/19\/%e3%82%a4%e3%83%96%e3%83%aa%e3%83%84%e3%83%a2%e3%83%9e%e3%83%96%e3%81%ab%e3%82%88%e3%82%8b%e5%9c%b0%e5%9b%ba%e3%82%81%e7%99%82%e6%b3%95%e3%81%8c%e6%9c%89%e5%8a%b9\/"},"modified":"2008-04-19T21:12:49","modified_gmt":"2008-04-19T12:12:49","slug":"%e3%82%a4%e3%83%96%e3%83%aa%e3%83%84%e3%83%a2%e3%83%9e%e3%83%96%e3%81%ab%e3%82%88%e3%82%8b%e5%9c%b0%e5%9b%ba%e3%82%81%e7%99%82%e6%b3%95%e3%81%8c%e6%9c%89%e5%8a%b9","status":"publish","type":"post","link":"https:\/\/haruko.km2m.net\/?p=47","title":{"rendered":"\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306b\u3088\u308b\u5730\u56fa\u3081\u7642\u6cd5\u304c\u6709\u52b9"},"content":{"rendered":"

\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306b\u3088\u308b\u5730\u56fa\u3081\u7642\u6cd5\u306b\u95a2\u3059\u308b\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u8a18\u4e8b\u3092\u307e\u3068\u3081\u3066\u307f\u307e\u3057\u305f\u3002 \u8a73\u3057\u304f\u306f\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u8981\u7d04\u306f\u3001\u65b0\u3057\u3044\u3082\u306e\u9806\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n

===========================================================<\/p>\n

\n2008. 4. 8
\n\u7b2c6\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a
\n\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e\u6cbb\u7642\u6226\u7565\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3059\u308b\u3010\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a2008\u3011<\/p>\n

\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306b\u304a\u3044\u3066\u3082\u3001\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306b\u3088\u308b\u5730\u56fa\u3081\u7642\u6cd5\u3067\u90e8\u5206\u5bdb\u89e3\u304b\u3089\u5b8c\u5168\u5bdb\u89e3\u3078\u8ee2\u5316\u3057\u3001\u7121\u6cbb\u7642\u7fa4\u306b\u6bd4\u3079\u3066\u3001\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u304c\u6709\u610f\u306b\u5ef6\u9577\u3059\u308b\u3053\u3068\u304c\u3001\u7b2c\u2162\u76f8\u81e8\u5e8a\u8a66\u9a13\uff08FIT\u8a66\u9a13\uff09\u3067\u793a\u3055\u308c\u305f\u3002\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u304c\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u6a19\u6e96\u7684\u6cbb\u7642\u306e1\u3064\u306b\u306a\u308b\u304b\u3069\u3046\u304b\u3001\u4eca\u5f8c\u306e\u6210\u679c\u304c\u5f85\u305f\u308c\u308b\u3002 <\/p>\n

http:\/\/medical.nikkeibp.co.jp\/leaf\/all\/gakkai\/jsmo2008\/200804\/506026.html<\/p>\n

\n2008. 3. 24
\nCHMP\u304c\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u5bfe\u8c61\u306b\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306e\u5730\u56fa\u3081\u7642\u6cd5\u306b\u3064\u3044\u3066\u80af\u5b9a\u7684\u610f\u898b<\/p>\n

\u3000\u30c9\u30a4\u30c4Bayer Schering\u793e\u306f\u30013\u670820\u65e5\u3001Commitee for Medical Products for Human Use\uff08CHMP\uff09\u304b\u3089\u3001\u6b27\u5dde\u3067\u306e\u672a\u6cbb\u7642\u306e\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u60a3\u8005\u306b\u304a\u3051\u308b\u5bdb\u89e3\u5c0e\u5165\u7642\u6cd5\u5f8c\u306e\u5730\u56fa\u3081\u7642\u6cd5\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3001\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\uff08\u5546\u54c1\u540d\u300c\u30bc\u30f4\u30a1\u30ea\u30f3\u30a4\u30c3\u30c8\u30ea\u30a6\u30e0(90Y)\u300d\uff09\u306e\u627f\u8a8d\u306b\u5bfe\u3059\u308b\u80af\u5b9a\u7684\u306a\u610f\u898b\u3092\u53d7\u3051\u53d6\u3063\u305f\u3068\u767a\u8868\u3057\u305f\u3002<\/p>\n

\u3000\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306f\u3001\u73fe\u5728\u3001\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3068\u306e\u4f75\u7528\u3067\u3001\u6210\u4eba\u306e\u518d\u767a\u6027\u96e3\u6cbb\u6027\u306eCD20\u967d\u6027\u6ffe\u80de\u6027B\u7d30\u80de\u6027\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u3078\u306e\u9069\u5fdc\u304c\u8a8d\u3081\u3089\u308c\u3066\u3044\u308b\u3002<\/p>\n

\u3000\u3053\u306eCHMP\u306e\u6c7a\u5b9a\u306f\u3001\u30d5\u30a7\u30fc\u30baIII\u81e8\u5e8a\u8a66\u9a13\u3067\u3042\u308bFIT\u8a66\u9a13\u3092\u30d9\u30fc\u30b9\u3068\u3057\u3066\u3044\u308b\u3002\u5730\u56fa\u3081\u7642\u6cd5\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u3068\u3057\u3066\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306f\u3001\u5730\u56fa\u3081\u7642\u6cd5\u3092\u884c\u308f\u306a\u304b\u3063\u305f\u7fa4\u306e\u7121\u5897\u60aa\u751f\u5b58\u671f\u959313.5\u30ab\u6708\u3068\u6bd4\u8f03\u3057\u306637\u30ab\u6708\u3068\u5ef6\u9577\u3057\u305f\uff08p<0.0001\uff09\u3002FIT\u8a66\u9a13\u306f\u3001\u5bdb\u89e3\u5c0e\u5165\u7642\u6cd5\u3067\u5b8c\u5168\u5bdb\u89e3\u3001\u4e0d\u78ba\u5b9a\u5b8c\u5168\u5bdb\u89e3\u3001\u90e8\u5206\u5bdb\u89e3\u304c\u5f97\u3089\u308c\u305f\u60a3\u8005\u3092\u3001\u7121\u4f5c\u70ba\u306b\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u3092\u6295\u4e0e\u3059\u308b\u7fa4\uff08208\u4eba\uff09\u3068\u66f4\u306a\u308b\u6cbb\u7642\u3092\u884c\u306a\u308f\u306a\u3044\u7fa4\uff08206\u4eba\uff09\u306b\u5272\u308a\u4ed8\u3051\u3066\u8a55\u4fa1\u3057\u305f\u3082\u306e\u3002\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u6295\u4e0e\u7fa4\u306f\u3001\uff0d7\u65e5\u76ee\u30680\u65e5\u76ee\u306b\u6297CD20\u6297\u4f53\u88fd\u5264\u306e\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3092250mg\/m2\u6295\u4e0e\u3057\u30010\u65e5\u76ee\u306b\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u3092\u4f53\u91cd1kg\u5f53\u305f\u308a0.4mCi\u6295\u4e0e\u3057\u3066\u3044\u308b\uff08\u6700\u9ad8\u306732mCi\uff09\u3002\n\uff08\u52a0\u85e4 \u52c7\u6cbb=\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u5225\u518a
\nhttp:\/\/medical.nikkeibp.co.jp\/leaf\/all\/search\/cancer\/news\/200803\/505799.html<\/p>\n

2007. 11. 14
\n\u9032\u884c\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u5730\u56fa\u3081\u7642\u6cd5\u306b\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u304c\u6709\u52b9<\/p>\n

\u3000\u9032\u884c\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u5730\u56fa\u3081\u7642\u6cd5\u306e\u7b2c\u4e00\u9078\u629e\u85ac\u3068\u3057\u3066\u653e\u5c04\u6027\u7269\u8cea\u30a4\u30c3\u30c8\u30ea\u30a6\u30e0\u3067\u6a19\u8b58\u3057\u305f\u6297CD20\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\uff08\u5546\u54c1\u540d\u300cZevalin\u300d\uff09\u304c\u6709\u52b9\u3067\u3042\u308b\u3053\u3068\u304c\u5927\u898f\u6a21\u56fd\u969b\u7121\u4f5c\u70ba\u5316\u30d5\u30a7\u30fc\u30baIII\u81e8\u5e8a\u8a66\u9a13FIT\uff08First-Line Indolent Trial\uff09\u306e\u7d50\u679c\u660e\u3089\u304b\u3068\u306a\u3063\u305f\u3002\u4e3b\u8981\u8a55\u4fa1\u30dd\u30a4\u30f3\u30c8\u3067\u3042\u3063\u305f\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u306e\u5ef6\u9577\u304c\u78ba\u8a8d\u3055\u308c\u305f\u3002\u30c9\u30a4\u30c4Bayer Schering Pharma\u793e\u304c11\u670812\u65e5\u306b\u767a\u8868\u3057\u305f\u3002<\/p>\n

\u3000\u4eca\u56de\u306e\u8a66\u9a13\u7d50\u679c\u3092\u57fa\u306bBayer Schering Pharma\u793e\u306f\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\u306b\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306e\u9032\u884c\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u5730\u56fa\u3081\u7642\u6cd5\u306e\u7b2c\u4e00\u9078\u629e\u85ac\u3068\u3057\u3066\u306e\u9069\u5fdc\u62e1\u5927\u7533\u8acb\u3092\u884c\u306a\u3063\u305f\u3002<\/p>\n

\u3000FIT\u8a66\u9a13\u306e\u8a73\u7d30\u306f12\u6708\u306b\u958b\u50ac\u3055\u308c\u308b\u7c73\u56fd\u8840\u6db2\u5b66\u4f1a\u3067\u767a\u8868\u3055\u308c\u308b\u4e88\u5b9a\u3060\u3002<\/p>\n

\uff08\u6a2a\u5c71 \u52c7\u751f=\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u5225\u518a\uff09
\nhttp:\/\/medical.nikkeibp.co.jp\/leaf\/all\/search\/cancer\/news\/200711\/504771.html<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306b\u3088\u308b\u5730\u56fa\u3081\u7642\u6cd5\u306b\u95a2\u3059\u308b\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u8a18\u4e8b\u3092\u307e\u3068\u3081\u3066\u307f\u307e\u3057\u305f\u3002 \u8a73\u3057\u304f\u306f\u65e5\u7d4c\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002 \u8981\u7d04\u306f\u3001\u65b0\u3057\u3044\u3082\u306e\u9806\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002 ======================== … <\/p>\n

“\u30a4\u30d6\u30ea\u30c4\u30e2\u30de\u30d6\u306b\u3088\u308b\u5730\u56fa\u3081\u7642\u6cd5\u304c\u6709\u52b9” \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-47","post","type-post","status-publish","format-standard","hentry","category-4"],"_links":{"self":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/47","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47"}],"version-history":[{"count":0,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/47\/revisions"}],"wp:attachment":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}